2016

Review article: novel methods for the treatment of non-alcoholic steatohepatitis – targeting the gut immune system to decrease the systemic inflammatory response without immune suppression
Y. Ilan
Alimentary Pharmacology & Therapeutics
December 2016


Liver resection for cancer: New developments in prediction, prevention and management of postresectional liver failure
Kim M.C. van Mierlo, Frank G. Schaap, Cornelis H.C. Dejong, Steven W.M. Olde Damink
Journal of Hepatology
December 2016


Sarcopenia from mechanism to diagnosis and treatment in liver disease
Srinivasan Dasarathy, Manuela Merli
Journal of Hepatology
December 2016


NAFLD and liver transplantation: Current burden and expected challenges
Raluca Pais, A. Sidney Barritt 4th, Yvon Calmus, Olivier Scatton, Thomas Runge, Pascal Lebray, Thierry Poynard, Vlad Ratziu, Filomena Conti
Journal of Hepatology
December 2016


Gamma-glutamyltransferase—friend or foe within? (pages 1723–1734)
Setor K. Kunutsor
Liver international
December 2016


Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis
Qiu-Feng He, Qiong-Fang Zhang, Da-Zhi Zhang
Digestive Diseases and Sciences
November 2016


Platelets: No longer bystanders in liver disease
Abhishek Chauhan, David H. Adams, Steve P. Watson, Patricia F. Lalor
Hepatology
November 2016


MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice
Parambir S. Dulai, Claude B. Sirlin, Rohit Loomba
Journal of Hepatology
November 2016


Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes? (pages 1563–1579)
Luca Valenti, Elisabetta Bugianesi, Utpal Pajvani and Giovanni Targher
Liver international
November 2016


NASH: A glance at the landscape of pharmacological treatment
Lucia Brodosi, Francesca Marchignoli, Maria Letizia Petroni, Giulio Marchesini
Annals Of Hepatology
October 2016


The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control
Jens Bukh
Journal of Hepatology
October 2016


HCV epidemiology in high-risk groups and the risk of reinfection
Håvard Midgard, Amanda Weir, Norah Palmateer, Vincent Lo Re III, Juan A. Pineda, Juan Macías, Olav Dalgard
Journal of Hepatology
October 2016


Diagnostics in hepatitis C: The end of response-guided therapy?
Benjamin Maasoumy, Johannes Vermehren
Journal of Hepatology
October 2016


Hepatitis C virus infection and chronic kidney disease: Time for reappraisal
Patrice Cacoub, Anne Claire Desbois, Corinne Isnard-Bagnis, Dario Rocatello, Clodoveo Ferri
Journal of Hepatology
October 2016


Reversion of disease manifestations after HCV eradication
Adriaan J. van der Meer, Marina Berenguer
Journal of Hepatology
October 2016


Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences
Zobair M. Younossi, Aybike Birerdinc, Linda Henry
Journal of Hepatology
October 2016


Management of the patient with SVR
Norah A. Terrault, Tarek I. Hassanein
Journal of Hepatology
October 2016


Second generation direct-acting antivirals – Do we expect major improvements?
Jordan J. Feld, Graham R. Foster
Journal of Hepatology
October 2016


Senescence in chronic liver disease: Is the future in aging?
Aloysious D. Aravinthan, Graeme J.M. Alexander
Journal of Hepatology
October 2016


Treatment of alcohol use disorders in patients with alcoholic liver disease
Giovanni Addolorato, Antonio Mirijello, Pablo Barrio, Antoni Gual
Journal of Hepatology
September 2016

Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis (pages 1239–1251)
Elena Raffetti, Giovanna Fattovich and Francesco Donato
Liver international
September 2016


Review article: novel therapies for hepatitis B virus cure – advances and perspectives (C.-L. Lin and J.-H. Kao
Alimentary Pharmacology & Therapeutics
August 2016


Alcoholic hepatitis: How far are we and where are we going?
Verónica Prado, Joan Caballería, Víctor Vargas, Ramón Bataller, José Altamirano
Annals Of Hepatology
August 2016


Hepatorenal syndrome: Current concepts related to diagnosis and management
Angelo Zambam De Mattos, Angelo Alves de Mattos, Nahum Méndez-Sánchez
Annals Of Hepatology
August 2016


AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF)
Women in Hepatology Group Italian Association for the Study of the Liver (AISF)
Digestive and Liver disease
August 2016


EASL Clinical Practice Guidelines on the management of benign liver tumours
European Association for the Study of the Liver (EASL)
Journal of Hepatology
August 2016


Update on alpha-1 antitrypsin deficiency: New therapies
David A. Lomas, John R. Hurst, Bibek Gooptu
Journal of Hepatology
August 2016


Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
Sven M. Francque, Denise van der Graaff, Wilhelmus J. Kwanten
Journal of Hepatology
August 2016

The role of endoscopy in the diagnosis and treatment of cystic pancreatic neoplasms
ASGE Standards of Practice Committee V. Raman Muthusamy, Vinay Chandrasekhara, Ruben D. Acosta, David H. Bruining, Krishnavel V. Chathadi, Mohamad A. Eloubeidi, Ashley L. Faulx, Lisa Fonkalsrud, Suryakanth R. Gurudu, Mouen A. Khashab, Shivangi Kothari, Jenifer R. Lightdale, Shabana F. Pasha, John R. Saltzman, Aasma Shaukat, Amy Wang, Julie Yang, Brooks D. Cash, John M. DeWitt
Gastrointestinal Endoscopy
July 2016

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
Hepatitis C
AASLD IDSA
Actualización permanente online.

Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
Jean-Michel Pawlotsky
Gastroenterology
July 2016

EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones
European Association for the Study of the Liver (EASL)
Journal of Hepatology
July 2016

Update on hepatitis E virology: Implications for clinical practice
Yannick Debing, Darius Moradpour, Johan Neyts, Jérôme Gouttenoire
Journal of Hepatology
July 2016

Diabetes mellitus in patients with cirrhosis: clinical implications and management
Laure Elkrief, Pierre-Emmanuel Rautou, Shiv Sarin, Dominique Valla, Valérie Paradis and Richard Moreau
Liver International
July 2016

New therapies for chronic hepatitis B (pages 775–782)
Maya Bitton Alaluf and Amir Shlomai
Liver International
June 2016

Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression? (pages 783–790)
Roberta D'Ambrosio and Massimo Colombo
Liver International
June 2016

Chronic hepatitis C virus infection, a new cardiovascular risk factor? (pages 621–627)
Fanny Domont and Patrice Cacoub
Liver International
May 2016

IgG4-related sclerosing cholangitis: all we need to know
Yoh Zen, Hiroshi Kawakami, Jung Hoon Kim
Journal of Gastroenterology
April 2016

Pregnancy and liver disease
Rachel H. Westbrook, Geoffrey Dusheiko, Catherine Williamson
Journal of Hepatology
April 2016

The enteric microbiome in hepatobiliary health and disease (pages 480–487)
James H. Tabibian, Cyril Varghese, Nicholas F. LaRusso and Steven P. O'Hara
Liver International
April 2016

Circadian Clock Control of Liver Metabolic Functions
Hans Reinke, Gad Asher
Gastroeneterology
March 2016

Insights into the diagnosis of hepatocellular carcinomas with hepatobiliary MRI
Valérie Vilgrain, Bernard E. Van Beers, Catherine M. Pastor
Journal of Hepatology
March 2016

Management of the critically ill patient with cirrhosis: A multidisciplinary perspective
Mitra K. Nadim, Francois Durand, John A. Kellum, Josh Levitsky, Jacqueline G. O’Leary, Constantine J. Karvellas, Jasmohan S. Bajaj, Andrew Davenport, Rajiv Jalan, Paolo Angeli, Stephen H. Caldwell, Javier Fernández, Claire Francoz, Guadalupe Garcia-Tsao, Pere Ginès, Michael G. Ison, David J. Kramer, Ravindra L. Mehta, Richard Moreau, David Mulligan, Jody C. Olson, Elizabeth A. Pomfret, Marco Senzolo, Randolph H. Steadman, Ram M. Subramanian, Jean-Louis Vincent, Yuri S. Genyk
Journal of Hepatology
March 2016

Pegylated interferon alfa for chronic hepatitis B: systematic review and meta-analysis
V. Kim, R. M. Abreu, D. M. Nakagawa, R. M. Baldassare, F. J. Carrilho and S. K. Ono
Journal of Viral Hepatitis
March 2016

You have free access to this contentEarly diagnosis of liver cancer: an appraisal of international recommendations and future perspectives (pages 166–176)
Cristina Della Corte, Michela Triolo, Massimo Iavarone and Angelo Sangiovanni
Liver International
February 2016

AASLD guidelines for treatment of chronic hepatitis B
Authors
Norah A. Terrault, Natalie H. Bzowej, Kyong‐Mi Chang, Jessica P. Hwang, Maureen M. Jonas, M. Hassan Murad
Hepatology
January 2016

Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis
Anna S.F. Lok, Brian J. McMahon, Robert S. Brown Jr., John B. Wong, Ahmed T. Ahmed, Wigdan Farah, Jehad Almasri, Fares Alahdab, Khalid Benkhadra, Mohamed A. Mouchli, et al
Hepatology
January 2016

Special Issue: Proceedings of the 9th Paris Hepatitis Conference. International Conference on the Management of Patients with Viral Hepatitis
Liver International
January 2016


2017 - 2016 - 2015 - 2014 - 2013 - 2012 -2011 -2010 - 2009 - 2008 - 2007 - 2006 - 2005 - 2004 - 2003 - 2002 - 2001 - 2000 - 1999 al 1998

 

 
 

 

 

Dirección: Urquiza 3100, Rosario (2000), Santa Fe, Argentina
e-mail: contactohepagastro@gmail.com
TEL: 0341-4393511

Diseño web IDEAS MED | Tabone Juan Pablo | www.ideasmed.com.ar |

Hepagastro | Dr. Federico Tanno | Todos los derechos reservados 2015.-